IDEAS AND REALITY IN THE DEVELOPMENT OF CANCER CHEMOTHERAPEUTIC-AGENTS, WITH PARTICULAR REFERENCE TO OXAZAPHOSPHORINE CYTOSTATICS

被引:17
作者
BROCK, N
机构
关键词
D O I
10.1007/BF00402768
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 12
页数:12
相关论文
共 56 条
[1]  
ARNOLD H, 1961, ARZNEIMITTEL-FORSCH, V11, P143
[2]   GE++ SYNTHESIS AND BREAKDOWN OF CYTOSTATICALLY ACTIVE N-PHOSPHAMIDE ESTERS OF THE BIS-(BETA-CHLORETHYL)-AMINE [J].
ARNOLD, H ;
BOURSEAUX, F .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1958, 70 (17-8) :539-544
[3]  
BIELICKI L, 1984, J CANCER RES CLIN, V108, P195
[4]   STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .1. EXPERIMENTAL STUDIES ON THE UROTOXICITY OF ALKYLATING COMPOUNDS [J].
BROCK, N ;
POHL, J ;
STEKAR, J .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (06) :595-607
[5]   STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .3. PROFILE OF ACTION OF SODIUM 2-MERCAPTOETHANE SULFONATE (MESNA) [J].
BROCK, N ;
POHL, J ;
STEKAR, J ;
SCHEEF, W .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12) :1377-&
[6]   STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .2. COMPARATIVE-STUDY ON THE UROPROTECTIVE EFFICACY OF THIOLS AND OTHER SULFUR-COMPOUNDS [J].
BROCK, N ;
POHL, J ;
STEKAR, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (11) :1155-1163
[7]  
BROCK N, 1976, CANCER TREAT REP, V60, P301
[8]  
BROCK N, 1977, Zeitschrift fuer Krebsforschung und Klinische Onkologie, V88, P185
[9]   PHARMACOKINETICS AND MECHANISM OF ACTION OF DETOXIFYING LOW-MOLECULAR-WEIGHT THIOLS [J].
BROCK, N ;
HILGARD, P ;
POHL, J ;
ORMSTAD, K ;
ORRENIUS, S .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 108 (01) :87-97
[10]  
BROCK N, 1980, BEITRAGE ONKOLOGIE, V5, P1